69 results on '"Catez F"'
Search Results
2. RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cells
- Author
-
Diaz J, Sébastien Durand, Isaac C, Meyronet D, Huyghe A, Gabut M, Bennychen B, Bruelle M, A Seyve, Catez F, Vanbelle C, Bourdelais F, Lavial F, Blin-Gonthier J, Emiliano P. Ricci, and Ducray F
- Subjects
Homeobox protein NANOG ,biology ,embryonic structures ,biology.protein ,Ribosome biogenesis ,Translation (biology) ,Stem cell ,PRC2 ,Induced pluripotent stem cell ,Embryonic stem cell ,Chromatin ,Cell biology - Abstract
Embryonic stem cell (ESC) fate decisions are regulated by a complex molecular circuitry that requires tight and coordinated gene expression regulations at multiple levels from chromatin organization to mRNA processing. Recently, ribosome biogenesis and translation have emerged as key regulatory pathways that efficiently control stem cell homeostasis. However, the molecular mechanisms underlying the regulation of these pathways remain largely unknown to date. Here, we analyzed the expression, in mouse ESCs, of over 300 genes involved in ribosome biogenesis and we identified RSL24D1 as the most differentially expressed between self-renewing and differentiated ESCs. RSL24D1 is highly expressed in multiple mouse pluripotent stem cell models and its expression profile is conserved in human ESCs. RSL24D1 is associated with nuclear pre-ribosomes and is required for the maturation and the synthesis of 60S subunits in mouse ESCs. Interestingly, RSL24D1 depletion significantly impairs global translation, particularly of key pluripotency factors, including POU5F1 and NANOG, as well as components of the polycomb repressive complex 2 (PRC2). Consistently, RSL24D1 is required for mouse ESC self-renewal and proliferation. Taken together, we show that RSL24D1-dependant ribosome biogenesis is required to both sustain the expression of pluripotent transcriptional programs and silence developmental programs, which concertedly dictate ESC homeostasis.
- Published
- 2021
3. Proffered Paper: The rRNA epigenetic hypothesis: role of ribosome heterogeneity in tumorigenesis
- Author
-
Marcel, V., primary, Van Long, F. Nguyen, additional, Pion, N., additional, Erales, J., additional, Bourdon, J.C., additional, Puisieux, A., additional, Motorine, I., additional, Bouvet, P., additional, Catez, F., additional, and Diaz, J.J., additional
- Published
- 2016
- Full Text
- View/download PDF
4. Ribosome biogenesis factors: novel clinical markers of breast cancer outcome
- Author
-
Van Long, F. Nguyen, primary, Pion, N., additional, Lardy-Cleaud, A., additional, Lavergne, E., additional, Bourdon, J.C., additional, Chabaud, S., additional, Treilleux, I., additional, Catez, F., additional, Diaz, J.J., additional, and Marcel, V., additional
- Published
- 2016
- Full Text
- View/download PDF
5. Down-regulation of nucleosomal inding protein HMGN1 expression during embrogenesis modulates Sox9 expression in chondrocytes
- Author
-
Furusawa, T., J. H., Lim, Catez, F., Birger, Y., Mackem, S., Bustin, M., Centre de génétique et de physiologie moléculaire et cellulaire (CGPhiMC), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), and Laviron, Nathalie
- Subjects
[SDV.BC]Life Sciences [q-bio]/Cellular Biology ,[SDV.BC] Life Sciences [q-bio]/Cellular Biology - Published
- 2006
6. Increased tumorigenicity and sensitivity to ionizing radiation upon loss of chromosomal protein HMGN1
- Author
-
Birger, Y., Catez, F., Furusawa, T., Jh, Lim, Prymakowska-Bosak, M., Kl, West, Yv, Postnikov, Dc, Haines, Bustin, M., Laviron, Nathalie, Centre de génétique et de physiologie moléculaire et cellulaire (CGPhiMC), Université Claude Bernard Lyon 1 (UCBL), and Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)
- Subjects
[SDV.BC]Life Sciences [q-bio]/Cellular Biology ,[SDV.BC] Life Sciences [q-bio]/Cellular Biology - Published
- 2005
7. Chromosomal protein HMGN1 modulates histone H3 phosphorylation
- Author
-
Jh, Lim, Catez, F., Birger, Y., Kl, West, Prymakowska-Bosak, M., Yv, Postikov, Bustin, M., Centre de génétique et de physiologie moléculaire et cellulaire (CGPhiMC), Université Claude Bernard Lyon 1 (UCBL), and Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)
- Subjects
[SDV.BC]Life Sciences [q-bio]/Cellular Biology - Published
- 2004
8. Dynamics and chromatin functions;
- Author
-
Catez, F., Jh, Lim, Hock, R., Yv, Postnivkov, Bustin, M., Centre de génétique et de physiologie moléculaire et cellulaire (CGPhiMC), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), and Laviron, Nathalie
- Subjects
[SDV.BC]Life Sciences [q-bio]/Cellular Biology ,[SDV.BC] Life Sciences [q-bio]/Cellular Biology - Published
- 2003
9. 869 - Ribosome biogenesis factors: novel clinical markers of breast cancer outcome
- Author
-
Van Long, F. Nguyen, Pion, N., Lardy-Cleaud, A., Lavergne, E., Bourdon, J.C., Chabaud, S., Treilleux, I., Catez, F., Diaz, J.J., and Marcel, V.
- Published
- 2016
- Full Text
- View/download PDF
10. 6 - Proffered Paper: The rRNA epigenetic hypothesis: role of ribosome heterogeneity in tumorigenesis.
- Author
-
Marcel, V., Van Long, F. Nguyen, Pion, N., Erales, J., Bourdon, J.C., Puisieux, A., Motorine, I., Bouvet, P., Catez, F., and Diaz, J.J.
- Published
- 2016
- Full Text
- View/download PDF
11. Mitochondrial Ribosomal Protein MRPS15 Is a Component of Cytosolic Ribosomes and Regulates Translation in Stressed Cardiomyocytes.
- Author
-
David F, Roussel E, Froment C, Draia-Nicolau T, Pujol F, Burlet-Schiltz O, Henras AK, Lacazette E, Morfoisse F, Tatin F, Diaz JJ, Catez F, Garmy-Susini B, and Prats AC
- Subjects
- Humans, Ribosomes metabolism, Polyribosomes metabolism, Cytosol metabolism, RNA, Messenger genetics, RNA, Messenger metabolism, Internal Ribosome Entry Sites, Protein Biosynthesis, Ribosomal Proteins genetics, Ribosomal Proteins metabolism, Myocytes, Cardiac metabolism
- Abstract
Regulation of mRNA translation is a crucial step in controlling gene expression in stressed cells, impacting many pathologies, including heart ischemia. In recent years, ribosome heterogeneity has emerged as a key control mechanism driving the translation of subsets of mRNAs. In this study, we investigated variations in ribosome composition in human cardiomyocytes subjected to endoplasmic reticulum stress induced by tunicamycin treatment. Our findings demonstrate that this stress inhibits global translation in cardiomyocytes while activating internal ribosome entry site (IRES)-dependent translation. Analysis of translating ribosome composition in stressed and unstressed cardiomyocytes was conducted using mass spectrometry. We observed no significant changes in ribosomal protein composition, but several mitochondrial ribosomal proteins (MRPs) were identified in cytosolic polysomes, showing drastic variations between stressed and unstressed cells. The most notable increase in polysomes of stressed cells was observed in MRPS15. Its interaction with ribosomal proteins was confirmed by proximity ligation assay (PLA) and immunoprecipitation, suggesting its intrinsic role as a ribosomal component during stress. Knock-down or overexpression experiments of MRPS15 revealed its role as an activator of IRES-dependent translation. Furthermore, polysome profiling after immunoprecipitation with anti-MRPS15 antibody revealed that the "MRPS15 ribosome" is specialized in translating mRNAs involved in the unfolded protein response.
- Published
- 2024
- Full Text
- View/download PDF
12. Spatial sequestration of activated-caspase 3 in aggresomes mediates resistance of neuroblastoma cell to bortezomib treatment.
- Author
-
Berthenet K, Aïmontché E, El Mrini S, Brière J, Pion N, Iacono I, Brejon S, Monier K, Catez F, Ichim G, Combaret V, Mertani HC, Diaz JJ, and Albaret MA
- Subjects
- Child, Humans, Bortezomib pharmacology, Bortezomib therapeutic use, Caspase 3 pharmacology, Cell Line, Tumor, Apoptosis, Neuroblastoma drug therapy, Neuroblastoma pathology, Antineoplastic Agents pharmacology, Antineoplastic Agents therapeutic use
- Abstract
Neuroblastoma (NB) is the most common pediatric tumor and is currently treated by several types of therapies including chemotherapies, such as bortezomib treatment. However, resistance to bortezomib is frequently observed by mechanisms that remain to be deciphered. Bortezomib treatment leads to caspase activation and aggresome formation. Using models of patients-derived NB cell lines with different levels of sensitivity to bortezomib, we show that the activated form of caspase 3 accumulates within aggresomes of NB resistant cells leading to an impairment of bortezomib-induced apoptosis and increased cell survival. Our findings unveil a new mechanism of resistance to chemotherapy based on an altered subcellular distribution of the executioner caspase 3. This mechanism could explain the resistance developed in NB patients treated with bortezomib, emphasizing the potential of drugs targeting aggresomes., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
13. Isocitrate dehydrogenase wt and IDHmut adult-type diffuse gliomas display distinct alterations in ribosome biogenesis and 2'O-methylation of ribosomal RNA.
- Author
-
Paraqindes H, Mourksi NE, Ballesta S, Hedjam J, Bourdelais F, Fenouil T, Picart T, Catez F, Combe T, Ferrari A, Kielbassa J, Thomas E, Tonon L, Viari A, Attignon V, Carrere M, Perrossier J, Giraud S, Vanbelle C, Gabut M, Bergeron D, Scott MS, Castro Vega L, Magne N, Huillard E, Sanson M, Meyronet D, Diaz JJ, Ducray F, Marcel V, and Durand S
- Subjects
- Adult, Humans, Isocitrate Dehydrogenase genetics, Isocitrate Dehydrogenase metabolism, RNA, Ribosomal genetics, RNA, Ribosomal metabolism, Methylation, Ribosomes genetics, Ribosomes metabolism, Ribosomes pathology, Mutation, Brain Neoplasms pathology, Glioblastoma genetics, Glioblastoma metabolism, Glioma pathology
- Abstract
Background: High-grade adult-type diffuse gliomas (HGGs) constitute a heterogeneous group of aggressive tumors that are mostly incurable. Recent advances highlighting the contribution of ribosomes to cancer development have offered new clinical perspectives. Here, we uncovered that isocitrate dehydrogenase (IDH)wt and IDHmut HGGs display distinct alterations of ribosome biology, in terms of rRNA epitranscriptomics and ribosome biogenesis, which could constitute novel hallmarks that can be exploited for the management of these pathologies., Methods: We analyzed (1) the ribosomal RNA 2'O-ribose methylation (rRNA 2'Ome) using RiboMethSeq and in-house developed bioinformatics tools (https://github.com/RibosomeCRCL/ribomethseq-nfandrRMSAnalyzer) on 3 independent cohorts compiling 71 HGGs (IDHwt n = 30, IDHmut n = 41) and 9 non-neoplastic samples, (2) the expression of ribosome biogenesis factors using medium throughput RT-qPCR as a readout of ribosome biogenesis, and (3) the sensitivity of 5 HGG cell lines to RNA Pol I inhibitors (CX5461, BMH-21)., Results: Unsupervised analysis demonstrated that HGGs could be distinguished based on their rRNA 2'Ome epitranscriptomic profile, with IDHwt glioblastomas displaying the most significant alterations of rRNA 2'Ome at specific sites. In contrast, IDHmut HGGs are largely characterized by an overexpression of ribosome biogenesis factors compared to non-neoplastic tissues or IDHwt glioblastomas. Finally, IDHmut HGG-derived spheroids display higher cytotoxicity to CX5461 than IDHwt glioblastoma, while all HGG spheroids display a similar cytotoxicity to BMH-21., Conclusions: In HGGs, IDH mutational status is associated with specific alterations of the ribosome biology and with distinct sensitivities to RNA Pol I inhibitors., (© The Author(s) 2023. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
14. Customization of the translational complex regulates mRNA-specific translation to control CNS regeneration.
- Author
-
Schaeffer J, Vilallongue N, Decourt C, Blot B, El Bakdouri N, Plissonnier E, Excoffier B, Paccard A, Diaz JJ, Humbert S, Catez F, Saudou F, Nawabi H, and Belin S
- Subjects
- Animals, Central Nervous System metabolism, Neurons metabolism, RNA, Messenger metabolism, Mammals metabolism, Axons metabolism, Nerve Regeneration genetics
- Abstract
In the adult mammalian central nervous system (CNS), axons fail to regenerate spontaneously after injury because of a combination of extrinsic and intrinsic factors. Despite recent advances targeting the intrinsic regenerative properties of adult neurons, the molecular mechanisms underlying axon regeneration are not fully understood. Here, we uncover a regulatory mechanism that controls the expression of key proteins involved in regeneration at the translational level. Our results show that mRNA-specific translation is critical for promoting axon regeneration. Indeed, we demonstrate that specific ribosome-interacting proteins, such as the protein Huntingtin (HTT), selectively control the translation of a specific subset of mRNAs. Moreover, modulating the expression of these translationally regulated mRNAs is crucial for promoting axon regeneration. Altogether, our findings highlight that selective translation through the customization of the translational complex is a key mechanism of axon regeneration with major implications in the development of therapeutic strategies for CNS repair., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
15. The stress sensor GCN2 differentially controls ribosome biogenesis in colon cancer according to the nutritional context.
- Author
-
Piecyk M, Triki M, Laval PA, Duret C, Fauvre J, Cussonneau L, Machon C, Guitton J, Rama N, Gibert B, Ichim G, Catez F, Bourdelais F, Durand S, Diaz JJ, Coste I, Renno T, Manié SN, Aznar N, Ansieau S, Ferraro-Peyret C, and Chaveroux C
- Abstract
Nutrient availability is a key determinant of tumor cell behavior. While nutrient-rich conditions favor proliferation and tumor growth, scarcity, and particularly glutamine starvation, promotes cell dedifferentiation and chemoresistance. Here, linking ribosome biogenesis plasticity with tumor cell fate, we uncover that the amino acid sensor general control non-derepressible 2 (GCN2; also known as eIF-2-alpha kinase 4) represses the expression of the precursor of ribosomal RNA (rRNA), 47S, under metabolic stress. We show that blockade of GCN2 triggers cell death by an irremediable nucleolar stress and subsequent TP53-mediated apoptosis in patient-derived models of colon adenocarcinoma (COAD). In nutrient-rich conditions, a cell-autonomous GCN2 activity supports cell proliferation by stimulating 47S rRNA transcription, independently of the canonical integrated stress response (ISR) axis. Impairment of GCN2 activity prevents nuclear translocation of methionyl-tRNA synthetase (MetRS), resulting in nucleolar stress, mTORC1 inhibition and, ultimately, autophagy induction. Inhibition of the GCN2-MetRS axis drastically improves the cytotoxicity of RNA polymerase I (RNA pol I) inhibitors, including the first-line chemotherapy oxaliplatin, on patient-derived COAD tumoroids. Our data thus reveal that GCN2 differentially controls ribosome biogenesis according to the nutritional context. Furthermore, pharmacological co-inhibition of the two GCN2 branches and RNA pol I activity may represent a valuable strategy for elimination of proliferative and metabolically stressed COAD cells., (© 2023 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.)
- Published
- 2023
- Full Text
- View/download PDF
16. Correction: The interferon stimulated gene 20 protein (ISG20) is an innate defense antiviral factor that discriminates self versus non-self translation.
- Author
-
Wu N, Nguyen XN, Wang L, Appourchaux R, Zhang C, Panthu B, Gruffat H, Journo C, Alais S, Qin J, Zhang N, Tartour K, Catez F, Mahieux R, Ohlmann T, Liu M, Du B, and Cimarelli A
- Abstract
[This corrects the article DOI: 10.1371/journal.ppat.1008093.]., (Copyright: © 2023 Wu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF
17. RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cells.
- Author
-
Durand S, Bruelle M, Bourdelais F, Bennychen B, Blin-Gonthier J, Isaac C, Huyghe A, Martel S, Seyve A, Vanbelle C, Adrait A, Couté Y, Meyronet D, Catez F, Diaz JJ, Lavial F, Ricci EP, Ducray F, and Gabut M
- Subjects
- Humans, Animals, Mice, Cell Differentiation genetics, Polycomb Repressive Complex 2 metabolism, Embryonic Stem Cells metabolism, Pluripotent Stem Cells
- Abstract
Embryonic stem cell (ESC) fate decisions are regulated by a complex circuitry that coordinates gene expression at multiple levels from chromatin to mRNA processing. Recently, ribosome biogenesis and translation have emerged as key pathways that efficiently control stem cell homeostasis, yet the underlying molecular mechanisms remain largely unknown. Here, we identified RSL24D1 as highly expressed in both mouse and human pluripotent stem cells. RSL24D1 is associated with nuclear pre-ribosomes and is required for the biogenesis of 60S subunits in mouse ESCs. Interestingly, RSL24D1 depletion significantly impairs global translation, particularly of key pluripotency factors and of components from the Polycomb Repressive Complex 2 (PRC2). While having a moderate impact on differentiation, RSL24D1 depletion significantly alters ESC self-renewal and lineage commitment choices. Altogether, these results demonstrate that RSL24D1-dependant ribosome biogenesis is both required to sustain the expression of pluripotent transcriptional programs and to silence PRC2-regulated developmental programs, which concertedly dictate ESC homeostasis., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
18. snoDB 2.0: an enhanced interactive database, specializing in human snoRNAs.
- Author
-
Bergeron D, Paraqindes H, Fafard-Couture É, Deschamps-Francoeur G, Faucher-Giguère L, Bouchard-Bourelle P, Abou Elela S, Catez F, Marcel V, and Scott MS
- Subjects
- Humans, Genomics, RNA, Ribosomal metabolism, RNA, Small Nucleolar metabolism, Databases, Genetic
- Abstract
snoDB is an interactive database of human small nucleolar RNAs (snoRNAs) that includes up-to-date information on snoRNA features, genomic location, conservation, host gene, snoRNA-RNA targets and snoRNA abundance and provides links to other resources. In the second edition of this database (snoDB 2.0), we added an entirely new section on ribosomal RNA (rRNA) chemical modifications guided by snoRNAs with easy navigation between the different rRNA versions used in the literature and experimentally measured levels of modification. We also included new layers of information, including snoRNA motifs, secondary structure prediction, snoRNA-protein interactions, copy annotations and low structure bias expression data in a wide panel of tissues and cell lines to bolster functional probing of snoRNA biology. Version 2.0 features updated identifiers, more links to external resources and duplicate entry resolution. As a result, snoDB 2.0, which is freely available at https://bioinfo-scottgroup.med.usherbrooke.ca/snoDB/, represents a one-stop shop for snoRNA features, rRNA modification targets, functional impact and potential regulators., (© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.)
- Published
- 2023
- Full Text
- View/download PDF
19. Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer.
- Author
-
Nguyen Van Long F, Lardy-Cleaud A, Carène D, Rossoni C, Catez F, Rollet P, Pion N, Monchiet D, Dolbeau A, Martin M, Simioni V, Bray S, Le Beherec D, Mosele F, Bouakka I, Colombe-Vermorel A, Odeyer L, Diot A, Jordan LB, Thompson AM, Jamen F, Dubois T, Chabaud S, Michiels S, Treilleux I, Bourdon JC, Pérol D, Puisieux A, André F, Diaz JJ, and Marcel V
- Subjects
- Biomarkers metabolism, Chromosomal Proteins, Non-Histone, Female, Humans, RNA, Messenger genetics, RNA, Messenger metabolism, Ribosomes genetics, Ribosomes metabolism, Breast Neoplasms genetics, Breast Neoplasms metabolism
- Abstract
Background: A current critical need remains in the identification of prognostic and predictive markers in early breast cancer. It appears that a distinctive trait of cancer cells is their addiction to hyperactivation of ribosome biogenesis. Thus, ribosome biogenesis might be an innovative source of biomarkers that remains to be evaluated., Methods: Here, fibrillarin (FBL) was used as a surrogate marker of ribosome biogenesis due to its essential role in the early steps of ribosome biogenesis and its association with poor prognosis in breast cancer when overexpressed. Using 3,275 non-metastatic primary breast tumors, we analysed FBL mRNA expression levels and protein nucleolar organisation. Usage of TCGA dataset allowed transcriptomic comparison between the different FBL expression levels-related breast tumours., Results: We unexpectedly discovered that in addition to breast tumours expressing high level of FBL, about 10% of the breast tumors express low level of FBL. A correlation between low FBL mRNA level and lack of FBL detection at protein level using immunohistochemistry was observed. Interestingly, multivariate analyses revealed that these low FBL tumors displayed poor outcome compared to current clinical gold standards. Transcriptomic data revealed that FBL expression is proportionally associated with distinct amount of ribosomes, low FBL level being associated with low amount of ribosomes. Moreover, the molecular programs supported by low and high FBL expressing tumors were distinct., Conclusion: Altogether, we identified FBL as a powerful ribosome biogenesis-related independent marker of breast cancer outcome. Surprisingly we unveil a dual association of the ribosome biogenesis FBL factor with prognosis. These data suggest that hyper- but also hypo-activation of ribosome biogenesis are molecular traits of distinct tumors., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
20. Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-tolerance.
- Author
-
Therizols G, Bash-Imam Z, Panthu B, Machon C, Vincent A, Ripoll J, Nait-Slimane S, Chalabi-Dchar M, Gaucherot A, Garcia M, Laforêts F, Marcel V, Boubaker-Vitre J, Monet MA, Bouclier C, Vanbelle C, Souahlia G, Berthel E, Albaret MA, Mertani HC, Prudhomme M, Bertrand M, David A, Saurin JC, Bouvet P, Rivals E, Ohlmann T, Guitton J, Dalla Venezia N, Pannequin J, Catez F, and Diaz JJ
- Subjects
- Cell Line, Tumor, Cell Survival drug effects, Colorectal Neoplasms genetics, Colorectal Neoplasms metabolism, Colorectal Neoplasms pathology, DNA Replication, DNA, Neoplasm metabolism, Drug Resistance, Neoplasm genetics, HCT116 Cells, Halogenation, Humans, RNA, Messenger genetics, RNA, Messenger metabolism, RNA, Ribosomal genetics, RNA, Ribosomal metabolism, Receptor, IGF Type 1 agonists, Receptor, IGF Type 1 metabolism, Ribosomes drug effects, Ribosomes genetics, Ribosomes metabolism, Xenograft Model Antitumor Assays, Antimetabolites, Antineoplastic pharmacology, Colorectal Neoplasms drug therapy, DNA, Neoplasm genetics, Drug Tolerance genetics, Fluorouracil pharmacology, Protein Biosynthesis drug effects, Receptor, IGF Type 1 genetics
- Abstract
Mechanisms of drug-tolerance remain poorly understood and have been linked to genomic but also to non-genomic processes. 5-fluorouracil (5-FU), the most widely used chemotherapy in oncology is associated with resistance. While prescribed as an inhibitor of DNA replication, 5-FU alters all RNA pathways. Here, we show that 5-FU treatment leads to the production of fluorinated ribosomes exhibiting altered translational activities. 5-FU is incorporated into ribosomal RNAs of mature ribosomes in cancer cell lines, colorectal xenografts, and human tumors. Fluorinated ribosomes appear to be functional, yet, they display a selective translational activity towards mRNAs depending on the nature of their 5'-untranslated region. As a result, we find that sustained translation of IGF-1R mRNA, which encodes one of the most potent cell survival effectors, promotes the survival of 5-FU-treated colorectal cancer cells. Altogether, our results demonstrate that "man-made" fluorinated ribosomes favor the drug-tolerant cellular phenotype by promoting translation of survival genes., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
21. DHX30 Coordinates Cytoplasmic Translation and Mitochondrial Function Contributing to Cancer Cell Survival.
- Author
-
Bosco B, Rossi A, Rizzotto D, Hamadou MH, Bisio A, Giorgetta S, Perzolli A, Bonollo F, Gaucherot A, Catez F, Diaz JJ, Dassi E, and Inga A
- Abstract
DHX30 was recently implicated in the translation control of mRNAs involved in p53-dependent apoptosis. Here, we show that DHX30 exhibits a more general function by integrating the activities of its cytoplasmic isoform and of the more abundant mitochondrial one. The depletion of both DHX30 isoforms in HCT116 cells leads to constitutive changes in polysome-associated mRNAs, enhancing the translation of mRNAs coding for cytoplasmic ribosomal proteins while reducing the translational efficiency of the nuclear-encoded mitoribosome mRNAs. Furthermore, the depletion of both DHX30 isoforms leads to higher global translation but slower proliferation and lower mitochondrial energy metabolism. Isoform-specific silencing supports a role for cytoplasmic DHX30 in modulating global translation. The impact on translation and proliferation was confirmed in U2OS and MCF7 cells. Exploiting RIP, eCLIP, and gene expression data, we identified fourteen mitoribosome transcripts we propose as direct DHX30 targets that can be used to explore the prognostic value of this mechanism in cancer. We propose that DHX30 contributes to cell homeostasis by coordinating ribosome biogenesis, global translation, and mitochondrial metabolism. Targeting DHX30 could, thus, expose a vulnerability in cancer cells.
- Published
- 2021
- Full Text
- View/download PDF
22. A novel view on an old drug, 5-fluorouracil: an unexpected RNA modifier with intriguing impact on cancer cell fate.
- Author
-
Chalabi-Dchar M, Fenouil T, Machon C, Vincent A, Catez F, Marcel V, Mertani HC, Saurin JC, Bouvet P, Guitton J, Venezia ND, and Diaz JJ
- Abstract
5-Fluorouracil (5-FU) is a chemotherapeutic drug widely used to treat patients with solid tumours, such as colorectal and pancreatic cancers. Colorectal cancer (CRC) is the second leading cause of cancer-related death and half of patients experience tumour recurrence. Used for over 60 years, 5-FU was long thought to exert its cytotoxic effects by altering DNA metabolism. However, 5-FU mode of action is more complex than previously anticipated since 5-FU is an extrinsic source of RNA modifications through its ability to be incorporated into most classes of RNA. In particular, a recent report highlighted that, by its integration into the most abundant RNA, namely ribosomal RNA (rRNA), 5-FU creates fluorinated active ribosomes and induces translational reprogramming. Here, we review the historical knowledge of 5-FU mode of action and discuss progress in the field of 5-FU-induced RNA modifications. The case of rRNA, the essential component of ribosome and translational activity, and the plasticity of which was recently associated with cancer, is highlighted. We propose that translational reprogramming, induced by 5-FU integration in ribosomes, contributes to 5-FU-driven cell plasticity and ultimately to relapse., (© The Author(s) 2021. Published by Oxford University Press on behalf of NAR Cancer.)
- Published
- 2021
- Full Text
- View/download PDF
23. Erratum: Ribosomal RNA 2' O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer.
- Author
-
Marcel V, Kielbassa J, Marchand V, Natchiar KS, Paraqindes H, Van Long FN, Ayadi L, Bourguignon-Igel V, Monaco PL, Monchiet D, Scott V, Tonon L, Bray SE, Diot A, Jordan LB, Thompson AM, Bourdon JC, Dubois T, André F, Catez F, Puisieux A, Motorin Y, Klaholz BP, Viari A, and Diaz JJ
- Abstract
[This corrects the article DOI: 10.1093/narcan/zcaa036.]., (© The Author(s) 2021. Published by Oxford University Press on behalf of NAR Cancer.)
- Published
- 2021
- Full Text
- View/download PDF
24. Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method.
- Author
-
Machon C, Catez F, Venezia ND, Vanhalle F, Guyot L, Vincent A, Garcia M, Roy B, Diaz JJ, and Guitton J
- Abstract
5-Fluorouracil (5-FU) is an anticancer drug extensively used for different cancers. Intracellular metabolic activation leads to several nucleoside and nucleotide metabolites essential to exert its cytotoxic activity on multiple cellular targets such as enzymes, DNA and RNA. In this paper, we describe the development of a method based on liquid chromatography coupled with high resolution mass spectrometry suitable for the simultaneous determination of the ten anabolic metabolites (nucleoside, nucleotide and sugar nucleotide) of 5-FU. The chromatographic separation was optimized on a porous graphitic carbon column allowing the analysis of the metabolites of 5-FU as well as endogenous nucleotides. The detection was performed on an Orbitrap® tandem mass spectrometer. Linearity of the method was verified in intracellular content and in RNA extracts. The limit of detection was equal to 12 pg injected on column for nucleoside metabolites of 5-FU and 150 pg injected on column for mono- and tri-phosphate nucleotide metabolites. Matrix effect was evaluated in cellular contents, DNA and RNA extracts for nucleoside and nucleotides metabolites. The method was successfully applied to i) measure the proportion of each anabolic metabolite of 5-FU in cellular contents, ii) follow the consequence of inhibition of enzymes on the endogenous nucleotide pools, iii) study the incorporation of metabolites of 5-FU into RNA and DNA, and iv) to determine the incorporation rate of 5-FUrd into 18 S and 28 S sub-units of rRNA., Competing Interests: The authors declare that there are no conflicts of interest., (© 2020 Xi'an Jiaotong University. Production and hosting by Elsevier B.V.)
- Published
- 2021
- Full Text
- View/download PDF
25. Ribosomal RNA 2'O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer.
- Author
-
Marcel V, Kielbassa J, Marchand V, Natchiar KS, Paraqindes H, Nguyen Van Long F, Ayadi L, Bourguignon-Igel V, Lo Monaco P, Monchiet D, Scott V, Tonon L, Bray SE, Diot A, Jordan LB, Thompson AM, Bourdon JC, Dubois T, André F, Catez F, Puisieux A, Motorin Y, Klaholz BP, Viari A, and Diaz JJ
- Abstract
Recent epitranscriptomics studies unravelled that ribosomal RNA (rRNA) 2'O-methylation is an additional layer of gene expression regulation highlighting the ribosome as a novel actor of translation control. However, this major finding lies on evidences coming mainly, if not exclusively, from cellular models. Using the innovative next-generation RiboMeth-seq technology, we established the first rRNA 2'O-methylation landscape in 195 primary human breast tumours. We uncovered the existence of compulsory/stable sites, which show limited inter-patient variability in their 2'O-methylation level, which map on functionally important sites of the human ribosome structure and which are surrounded by variable sites found from the second nucleotide layers. Our data demonstrate that some positions within the rRNA molecules can tolerate absence of 2'O-methylation in tumoral and healthy tissues. We also reveal that rRNA 2'O-methylation exhibits intra- and inter-patient variability in breast tumours. Its level is indeed differentially associated with breast cancer subtype and tumour grade. Altogether, our rRNA 2'O-methylation profiling of a large-scale human sample collection provides the first compelling evidence that ribosome variability occurs in humans and suggests that rRNA 2'O-methylation might represent a relevant element of tumour biology useful in clinic. This novel variability at molecular level offers an additional layer to capture the cancer heterogeneity and associates with specific features of tumour biology thus offering a novel targetable molecular signature in cancer., (© The Author(s) 2020. Published by Oxford University Press on behalf of NAR Cancer.)
- Published
- 2020
- Full Text
- View/download PDF
26. Ribosome Biogenesis Alterations in Colorectal Cancer.
- Author
-
Nait Slimane S, Marcel V, Fenouil T, Catez F, Saurin JC, Bouvet P, Diaz JJ, and Mertani HC
- Subjects
- Animals, Colorectal Neoplasms genetics, Genes, Tumor Suppressor, Humans, Models, Biological, RNA, Ribosomal biosynthesis, Colorectal Neoplasms metabolism, Organelle Biogenesis, Ribosomes metabolism
- Abstract
Many studies have focused on understanding the regulation and functions of aberrant protein synthesis in colorectal cancer (CRC), leaving the ribosome, its main effector, relatively underappreciated in CRC. The production of functional ribosomes is initiated in the nucleolus, requires coordinated ribosomal RNA (rRNA) processing and ribosomal protein (RP) assembly, and is frequently hyperactivated to support the needs in protein synthesis essential to withstand unremitting cancer cell growth. This elevated ribosome production in cancer cells includes a strong alteration of ribosome biogenesis homeostasis that represents one of the hallmarks of cancer cells. None of the ribosome production steps escape this cancer-specific dysregulation. This review summarizes the early and late steps of ribosome biogenesis dysregulations described in CRC cell lines, intestinal organoids, CRC stem cells and mouse models, and their possible clinical implications. We highlight how this cancer-related ribosome biogenesis, both at quantitative and qualitative levels, can lead to the synthesis of ribosomes favoring the translation of mRNAs encoding hyperproliferative and survival factors. We also discuss whether cancer-related ribosome biogenesis is a mere consequence of cancer progression or is a causal factor in CRC, and how altered ribosome biogenesis pathways can represent effective targets to kill CRC cells. The association between exacerbated CRC cell growth and alteration of specific steps of ribosome biogenesis is highlighted as a key driver of tumorigenesis, providing promising perspectives for the implementation of predictive biomarkers and the development of new therapeutic drugs.
- Published
- 2020
- Full Text
- View/download PDF
27. Uncovering the Translational Regulatory Activity of the Tumor Suppressor BRCA1.
- Author
-
Berthel E, Vincent A, Eberst L, Torres AG, Dacheux E, Rey C, Marcel V, Paraqindes H, Lachuer J, Catez F, Pouplana LR, Treilleux I, Diaz JJ, and Venezia ND
- Subjects
- Adult, Aged, BRCA1 Protein metabolism, Female, Genes, Tumor Suppressor, Humans, Middle Aged, Transfection, Triple Negative Breast Neoplasms metabolism, Triple Negative Breast Neoplasms pathology, BRCA1 Protein genetics, Triple Negative Breast Neoplasms genetics
- Abstract
BRCA1 inactivation is a hallmark of familial breast cancer, often associated with aggressive triple negative breast cancers. BRCA1 is a tumor suppressor with known functions in DNA repair, transcription regulation, cell cycle control, and apoptosis. In the present study, we demonstrate that BRCA1 is also a translational regulator. We previously showed that BRCA1 was implicated in translation regulation. Here, we asked whether translational control could be a novel function of BRCA1 that contributes to its tumor suppressive activity. A combination of RNA-binding protein immunoprecipitation, microarray analysis, and polysome profiling, was used to identify the mRNAs that were specifically deregulated under BRCA1 deficiency. Western blot analysis allowed us to confirm at the protein level the deregulated translation of a subset of mRNAs. A unique and dedicated cohort of patients with documented germ-line BRCA1 pathogenic variant statues was set up, and tissue microarrays with the biopsies of these patients were constructed and analyzed by immunohistochemistry for their content in each candidate protein. Here, we show that BRCA1 translationally regulates a subset of mRNAs with which it associates. These mRNAs code for proteins involved in major programs in cancer. Accordingly, the level of these key proteins is correlated with BRCA1 status in breast cancer cell lines and in patient breast tumors. ADAT2, one of these key proteins, is proposed as a predictive biomarker of efficacy of treatments recently recommended to patients with BRCA1 deficiency. This study proposes that translational control may represent a novel molecular mechanism with potential clinical impact through which BRCA1 is a tumor suppressor.
- Published
- 2020
- Full Text
- View/download PDF
28. Actualités en recherche en oncologie : l’essentiel du 4 e Symposium International 2019 du Centre de Recherche en Cancérologie de Lyon.
- Author
-
Catez F, Dalla-Venezia N, Diaz JJ, Dubois B, Ferrari A, Guyot B, Marcel V, Ouzounova M, Pommier RM, Viari A, and Mehlen P
- Published
- 2020
- Full Text
- View/download PDF
29. The interferon stimulated gene 20 protein (ISG20) is an innate defense antiviral factor that discriminates self versus non-self translation.
- Author
-
Wu N, Nguyen XN, Wang L, Appourchaux R, Zhang C, Panthu B, Gruffat H, Journo C, Alais S, Qin J, Zhang N, Tartour K, Catez F, Mahieux R, Ohlmann T, Liu M, Du B, and Cimarelli A
- Subjects
- Animals, Exoribonucleases physiology, HeLa Cells, Humans, Mice, Mice, Knockout, RNA Stability, RNA, Viral genetics, Vesicular Stomatitis drug therapy, Vesicular Stomatitis virology, Vesiculovirus drug effects, Antiviral Agents pharmacology, Exoribonucleases pharmacology, Protein Biosynthesis, RNA, Viral metabolism, Vesicular Stomatitis immunology, Vesiculovirus immunology, Virus Replication drug effects
- Abstract
ISG20 is a broad spectrum antiviral protein thought to directly degrade viral RNA. However, this mechanism of inhibition remains controversial. Using the Vesicular Stomatitis Virus (VSV) as a model RNA virus, we show here that ISG20 interferes with viral replication by decreasing protein synthesis in the absence of RNA degradation. Importantly, we demonstrate that ISG20 exerts a translational control over a large panel of non-self RNA substrates including those originating from transfected DNA, while sparing endogenous transcripts. This activity correlates with the protein's ability to localize in cytoplasmic processing bodies. Finally, these functions are conserved in the ISG20 murine ortholog, whose genetic ablation results in mice with increased susceptibility to viral infection. Overall, our results posit ISG20 as an important defense factor able to discriminate the self/non-self origins of the RNA through translation modulation., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2019
- Full Text
- View/download PDF
30. Ribosomal Proteins Regulate MHC Class I Peptide Generation for Immunosurveillance.
- Author
-
Wei J, Kishton RJ, Angel M, Conn CS, Dalla-Venezia N, Marcel V, Vincent A, Catez F, Ferré S, Ayadi L, Marchand V, Dersh D, Gibbs JS, Ivanov IP, Fridlyand N, Couté Y, Diaz JJ, Qian SB, Staudt LM, Restifo NP, and Yewdell JW
- Subjects
- Animals, Cell Line, Tumor, Coculture Techniques, HEK293 Cells, Histocompatibility Antigens Class I immunology, Host-Pathogen Interactions, Humans, Immunologic Surveillance, Influenza A virus immunology, Influenza A virus pathogenicity, Melanoma immunology, Melanoma metabolism, Mice, Inbred C57BL, Mice, Transgenic, Ribosomal Proteins genetics, Ribosome Subunits, Large, Eukaryotic genetics, Ribosome Subunits, Small, Eukaryotic genetics, Skin Neoplasms immunology, Skin Neoplasms metabolism, T-Lymphocytes immunology, T-Lymphocytes virology, Antigen Presentation, Histocompatibility Antigens Class I biosynthesis, Ribosomal Proteins metabolism, Ribosome Subunits, Large, Eukaryotic metabolism, Ribosome Subunits, Small, Eukaryotic metabolism, T-Lymphocytes metabolism
- Abstract
The MHC class I antigen presentation system enables T cell immunosurveillance of cancers and viruses. A substantial fraction of the immunopeptidome derives from rapidly degraded nascent polypeptides (DRiPs). By knocking down each of the 80 ribosomal proteins, we identified proteins that modulate peptide generation without altering source protein expression. We show that 60S ribosomal proteins L6 (RPL6) and RPL28, which are adjacent on the ribosome, play opposite roles in generating an influenza A virus-encoded peptide. Depleting RPL6 decreases ubiquitin-dependent peptide presentation, whereas depleting RPL28 increases ubiquitin-dependent and -independent peptide presentation. 40S ribosomal protein S28 (RPS28) knockdown increases total peptide supply in uninfected cells by increasing DRiP synthesis from non-canonical translation of "untranslated" regions and non-AUG start codons and sensitizes tumor cells for T cell targeting. Our findings raise the possibility of modulating immunosurveillance by pharmaceutical targeting ribosomes., (Published by Elsevier Inc.)
- Published
- 2019
- Full Text
- View/download PDF
31. Emerging Role of Eukaryote Ribosomes in Translational Control.
- Author
-
Dalla Venezia N, Vincent A, Marcel V, Catez F, and Diaz JJ
- Subjects
- Animals, Eukaryotic Cells, Humans, RNA, Messenger genetics, RNA, Messenger metabolism, RNA, Ribosomal genetics, RNA, Ribosomal metabolism, Ribosomal Proteins metabolism, Eukaryota genetics, Eukaryota metabolism, Gene Expression Regulation, Protein Biosynthesis, Ribosomes metabolism
- Abstract
Translation is one of the final steps that regulate gene expression. The ribosome is the effector of translation through to its role in mRNA decoding and protein synthesis. Many mechanisms have been extensively described accounting for translational regulation. However it emerged only recently that ribosomes themselves could contribute to this regulation. Indeed, though it is well-known that the translational efficiency of the cell is linked to ribosome abundance, studies recently demonstrated that the composition of the ribosome could alter translation of specific mRNAs. Evidences suggest that according to the status, environment, development, or pathological conditions, cells produce different populations of ribosomes which differ in their ribosomal protein and/or RNA composition. Those observations gave rise to the concept of "specialized ribosomes", which proposes that a unique ribosome composition determines the translational activity of this ribosome. The current review will present how technological advances have participated in the emergence of this concept, and to which extent the literature sustains this concept today.
- Published
- 2019
- Full Text
- View/download PDF
32. Ribosome biogenesis: An emerging druggable pathway for cancer therapeutics.
- Author
-
Catez F, Dalla Venezia N, Marcel V, Zorbas C, Lafontaine DLJ, and Diaz JJ
- Subjects
- Humans, Molecular Targeted Therapy methods, Neoplasms drug therapy, Neoplasms pathology, RNA, Ribosomal metabolism, Antineoplastic Agents pharmacology, Ribosomes drug effects, Ribosomes metabolism
- Abstract
Ribosomes are nanomachines essential for protein production in all living cells. Ribosome synthesis increases in cancer cells to cope with a rise in protein synthesis and sustain unrestricted growth. This increase in ribosome biogenesis is reflected by severe morphological alterations of the nucleolus, the cell compartment where the initial steps of ribosome biogenesis take place. Ribosome biogenesis has recently emerged as an effective target in cancer therapy, and several compounds that inhibit ribosome production or function, killing preferentially cancer cells, have entered clinical trials. Recent research indicates that cells express heterogeneous populations of ribosomes and that the composition of ribosomes may play a key role in tumorigenesis, exposing novel therapeutic opportunities. Here, we review recent data demonstrating that ribosome biogenesis is a promising druggable pathway in cancer therapy, and discuss future research perspectives., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
33. Deletion 6q Drives T-cell Leukemia Progression by Ribosome Modulation.
- Author
-
Gachet S, El-Chaar T, Avran D, Genesca E, Catez F, Quentin S, Delord M, Thérizols G, Briot D, Meunier G, Hernandez L, Pla M, Smits WK, Buijs-Gladdines JG, Van Loocke W, Menschaert G, André-Schmutz I, Taghon T, Van Vlierberghe P, Meijerink JP, Baruchel A, Dombret H, Clappier E, Diaz JJ, Gazin C, de Thé H, Sigaux F, and Soulier J
- Subjects
- Animals, Cell Line, Tumor, Chromosomes, Human, Pair 6, Disease Progression, Gene Expression Profiling, Haploinsufficiency, Heterogeneous-Nuclear Ribonucleoproteins metabolism, Humans, Leukemia, T-Cell metabolism, Leukemia, T-Cell pathology, Mice, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma genetics, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma metabolism, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma pathology, RNA Interference, RNA, Long Noncoding metabolism, Transplantation, Heterologous, Chromosome Deletion, Heterogeneous-Nuclear Ribonucleoproteins genetics, Leukemia, T-Cell genetics, RNA, Long Noncoding genetics, Ribosomes metabolism
- Abstract
Deletion of chromosome 6q is a well-recognized abnormality found in poor-prognosis T-cell acute lymphoblastic leukemia (T-ALL). Using integrated genomic approaches, we identified two candidate haploinsufficient genes contiguous at 6q14, SYNCRIP (encoding hnRNP-Q) and SNHG5 (that hosts snoRNAs), both involved in regulating RNA maturation and translation. Combined silencing of both genes, but not of either gene alone, accelerated leukemogeneis in a Tal1/Lmo1/Notch1 -driven mouse model, demonstrating the tumor-suppressive nature of the two-gene region. Proteomic and translational profiling of cells in which we engineered a short 6q deletion by CRISPR/Cas9 genome editing indicated decreased ribosome and mitochondrial activities, suggesting that the resulting metabolic changes may regulate tumor progression. Indeed, xenograft experiments showed an increased leukemia-initiating cell activity of primary human leukemic cells upon coextinction of SYNCRIP and SNHG5. Our findings not only elucidate the nature of 6q deletion but also highlight the role of ribosomes and mitochondria in T-ALL tumor progression. SIGNIFICANCE: The oncogenic role of 6q deletion in T-ALL has remained elusive since this chromosomal abnormality was first identified more than 40 years ago. We combined genomic analysis and functional models to show that the codeletion of two contiguous genes at 6q14 enhances malignancy through deregulation of a ribosome-mitochondria axis, suggesting the potential for therapeutic intervention. This article is highlighted in the In This Issue feature, p. 1494 ., (©2018 American Association for Cancer Research.)
- Published
- 2018
- Full Text
- View/download PDF
34. Externalized Keratin 8: A Target at the Interface of Microenvironment and Intracellular Signaling in Colorectal Cancer Cells.
- Author
-
Albaret MA, Vermot-Desroches C, Paré A, Roca-Martinez JX, Malet L, Esseily J, Gerossier L, Brière J, Pion N, Marcel V, Catez F, De Souza G, Vuillermoz B, Doerflinger F, Lavocat E, Subiger O, Rousset C, Bresson C, Mandon E, Jawhari A, Falson P, Jasmin M, Coute Y, Mertani HC, Saintigny P, and Diaz JJ
- Abstract
Accumulating evidence supports the remarkable presence at the membrane surface of cancer cells of proteins, which are normally expressed in the intracellular compartment. Although these proteins, referred to as externalized proteins, represent a highly promising source of accessible and druggable targets for cancer therapy, the mechanisms via which they impact cancer biology remain largely unexplored. The aim of this study was to expose an externalized form of cytokeratin 8 (eK8) as a key player of colorectal tumorigenesis and characterize its mode of action. To achieve this, we generated a unique antagonist monoclonal antibody (D-A10 MAb) targeting an eight-amino-acid-long domain of eK8, which enabled us to ascertain the pro-tumoral activity of eK8 in both KRAS -mutant and wild-type colorectal cancers (CRC). We showed that this pro-tumoral activity involves a bidirectional eK8-dependent control of caspase-mediated apoptosis in vivo and of the plasminogen-induced invasion process in cellulo. Furthermore, we demonstrated that eK8 is anchored at the plasma membrane supporting this dual function. We, therefore, identified eK8 as an innovative therapeutic target in CRC and provided a unique MAb targeting eK8 that displays anti-neoplastic activities that could be useful to treat CRC, including those harboring KRAS mutations.
- Published
- 2018
- Full Text
- View/download PDF
35. 2'-O-Methylation of Ribosomal RNA: Towards an Epitranscriptomic Control of Translation?
- Author
-
Monaco PL, Marcel V, Diaz JJ, and Catez F
- Subjects
- Epigenesis, Genetic genetics, Methylation, Protein Biosynthesis, RNA Processing, Post-Transcriptional genetics, RNA, Ribosomal genetics, Ribosomes genetics, Transcriptome genetics
- Abstract
Ribosomal RNA (rRNA) undergoes post-transcriptional modification of over 200 nucleotides, predominantly 2'-O-methylation (2'-O-Me). 2'-O-Methylation protects RNA from hydrolysis and modifies RNA strand flexibility but does not contribute to Watson-Crick base pairing. The contribution of 2'-O-Me to the translational capacity of ribosomes has been established. Yet, how 2'-O-Me participates in ribosome biogenesis and ribosome functioning remains unclear. The development of 2'-O-Me quantitative mapping methods has contributed to the demonstration that these modifications are not constitutive but rather provide heterogeneity to the ribosomal population. Moreover, recent advances in ribosome structure analysis and in vitro translation assays have proven, for the first time, that 2'-O-Me contributes to regulating protein synthesis. This review highlights the recent data exploring the impact of 2'-O-Me on ribosome structure and function, and the emerging idea that the rRNA epitranscriptome is involved in translational control.
- Published
- 2018
- Full Text
- View/download PDF
36. Evidence for rRNA 2'-O-methylation plasticity: Control of intrinsic translational capabilities of human ribosomes.
- Author
-
Erales J, Marchand V, Panthu B, Gillot S, Belin S, Ghayad SE, Garcia M, Laforêts F, Marcel V, Baudin-Baillieu A, Bertin P, Couté Y, Adrait A, Meyer M, Therizols G, Yusupov M, Namy O, Ohlmann T, Motorin Y, Catez F, and Diaz JJ
- Subjects
- Chromosomal Proteins, Non-Histone genetics, Chromosomal Proteins, Non-Histone metabolism, Gene Expression Regulation, Gene Knockdown Techniques, HeLa Cells, Humans, Methylation, Protein Biosynthesis, RNA, Ribosomal metabolism
- Abstract
Ribosomal RNAs (rRNAs) are main effectors of messenger RNA (mRNA) decoding, peptide-bond formation, and ribosome dynamics during translation. Ribose 2'-O-methylation (2'-O-Me) is the most abundant rRNA chemical modification, and displays a complex pattern in rRNA. 2'-O-Me was shown to be essential for accurate and efficient protein synthesis in eukaryotic cells. However, whether rRNA 2'-O-Me is an adjustable feature of the human ribosome and a means of regulating ribosome function remains to be determined. Here we challenged rRNA 2'-O-Me globally by inhibiting the rRNA methyl-transferase fibrillarin in human cells. Using RiboMethSeq, a nonbiased quantitative mapping of 2'-O-Me, we identified a repertoire of 2'-O-Me sites subjected to variation and demonstrate that functional domains of ribosomes are targets of 2'-O-Me plasticity. Using the cricket paralysis virus internal ribosome entry site element, coupled to in vitro translation, we show that the intrinsic capability of ribosomes to translate mRNAs is modulated through a 2'-O-Me pattern and not by nonribosomal actors of the translational machinery. Our data establish rRNA 2'-O-Me plasticity as a mechanism providing functional specificity to human ribosomes., Competing Interests: The authors declare no conflict of interest.
- Published
- 2017
- Full Text
- View/download PDF
37. Translational reprogramming of colorectal cancer cells induced by 5-fluorouracil through a miRNA-dependent mechanism.
- Author
-
Bash-Imam Z, Thérizols G, Vincent A, Lafôrets F, Polay Espinoza M, Pion N, Macari F, Pannequin J, David A, Saurin JC, Mertani HC, Textoris J, Auboeuf D, Catez F, Dalla Venezia N, Dutertre M, Marcel V, and Diaz JJ
- Subjects
- Cellular Reprogramming, Colonic Neoplasms genetics, Colorectal Neoplasms genetics, DNA-Binding Proteins genetics, DNA-Binding Proteins metabolism, Drug Resistance, Neoplasm, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, HCT116 Cells, HT29 Cells, Humans, Protein Biosynthesis drug effects, Transcription Factors genetics, Transcription Factors metabolism, Colonic Neoplasms therapy, Colorectal Neoplasms therapy, Fluorouracil therapeutic use, MicroRNAs genetics, RNA, Messenger genetics
- Abstract
5-Fluorouracil (5-FU) is a widely used chemotherapeutic drug in colorectal cancer. Previous studies showed that 5-FU modulates RNA metabolism and mRNA expression. In addition, it has been reported that 5-FU incorporates into the RNAs constituting the translational machinery and that 5-FU affects the amount of some mRNAs associated with ribosomes. However, the impact of 5-FU on translational regulation remains unclear. Using translatome profiling, we report that a clinically relevant dose of 5-FU induces a translational reprogramming in colorectal cancer cell lines. Comparison of mRNA distribution between polysomal and non-polysomal fractions in response to 5-FU treatment using microarray quantification identified 313 genes whose translation was selectively regulated. These regulations were mostly stimulatory (91%). Among these genes, we showed that 5-FU increases the mRNA translation of HIVEP2, which encodes a transcription factor whose translation in normal condition is known to be inhibited by mir-155. In response to 5-FU, the expression of mir-155 decreases thus stimulating the translation of HIVEP2 mRNA. Interestingly, the 5-FU-induced increase in specific mRNA translation was associated with reduction of global protein synthesis. Altogether, these findings indicate that 5-FU promotes a translational reprogramming leading to the increased translation of a subset of mRNAs that involves at least for some of them, miRNA-dependent mechanisms. This study supports a still poorly evaluated role of translational control in drug response.
- Published
- 2017
- Full Text
- View/download PDF
38. Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients.
- Author
-
Marcel V, Catez F, Berger CM, Perrial E, Plesa A, Thomas X, Mattei E, Hayette S, Saintigny P, Bouvet P, Diaz JJ, and Dumontet C
- Subjects
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Case-Control Studies, Child, Child, Preschool, Female, Gene Expression Profiling, Humans, Leukemia, Myeloid, Acute metabolism, Male, Middle Aged, Nuclear Proteins genetics, Prognosis, RNA, Messenger genetics, RNA, Messenger metabolism, RNA, Neoplasm genetics, RNA, Neoplasm metabolism, Ribosomes genetics, Ribosomes metabolism, Up-Regulation, Young Adult, Nucleolin, Biomarkers, Tumor genetics, Leukemia, Myeloid, Acute genetics, Phosphoproteins genetics, RNA-Binding Proteins genetics
- Abstract
Acute myeloid leukemia (AML) is a heterogeneous disease. Prognosis is mainly influenced by patient age at diagnosis and cytogenetic alterations, two of the main factors currently used in AML patient risk stratification. However, additional criteria are required to improve the current risk classification and better adapt patient care. In neoplastic cells, ribosome biogenesis is increased to sustain the high proliferation rate and ribosome composition is altered to modulate specific gene expression driving tumorigenesis. Here, we investigated the usage of ribosome biogenesis factors as clinical markers in adult patients with AML. We showed that nucleoli, the nucleus compartments where ribosome production takes place, are modified in AML by analyzing a panel of AML and healthy donor cells using immunofluorescence staining. Using four AML series, including the TCGA dataset, altogether representing a total of about 270 samples, we showed that not all factors involved in ribosome biogenesis have clinical values although ribosome biogenesis is increased in AML. Interestingly, we identified the regulator of ribosome production nucleolin (NCL) as over-expressed in AML blasts. Moreover, we found in two series that high NCL mRNA expression level was associated with a poor overall survival, particular in elderly patients. Multivariate analyses taking into account age and cytogenetic risk indicated that NCL expression in blast cells is an independent marker of reduced survival. Our study identifies NCL as a potential novel prognostic factor in AML. Altogether, our results suggest that the ribosome biogenesis pathway may be of interest as clinical markers in AML., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2017
- Full Text
- View/download PDF
39. Ribosome heterogeneity in tumorigenesis: the rRNA point of view.
- Author
-
Marcel V, Catez F, and Diaz JJ
- Abstract
The "specialized ribosome" concept proposes that ribosome variants are produced and differentially regulate translation. Examples supporting this notion demonstrated heterogeneity of ribosomal protein composition. However, ribosome translational activity is carried out by rRNA. We, and others, recently showed that rRNA heterogeneity regulates translation to generate distinct translatomes promoting tumorigenesis.
- Published
- 2015
- Full Text
- View/download PDF
40. Detection of the genome and transcripts of a persistent DNA virus in neuronal tissues by fluorescent in situ hybridization combined with immunostaining.
- Author
-
Catez F, Rousseau A, Labetoulle M, and Lomonte P
- Subjects
- Animals, DNA, Viral analysis, DNA, Viral genetics, Female, Immunoenzyme Techniques, Mice, Mice, Inbred BALB C, Microscopy, Confocal, RNA, Viral analysis, RNA, Viral genetics, Fluorescent Antibody Technique methods, Genome, Viral, Herpesvirus 1, Human genetics, In Situ Hybridization, Fluorescence methods, Neurons virology
- Abstract
Single cell codetection of a gene, its RNA product and cellular regulatory proteins is critical to study gene expression regulation. This is a challenge in the field of virology; in particular for nuclear-replicating persistent DNA viruses that involve animal models for their study. Herpes simplex virus type 1 (HSV-1) establishes a life-long latent infection in peripheral neurons. Latent virus serves as reservoir, from which it reactivates and induces a new herpetic episode. The cell biology of HSV-1 latency remains poorly understood, in part due to the lack of methods to detect HSV-1 genomes in situ in animal models. We describe a DNA-fluorescent in situ hybridization (FISH) approach efficiently detecting low-copy viral genomes within sections of neuronal tissues from infected animal models. The method relies on heat-based antigen unmasking, and directly labeled home-made DNA probes, or commercially available probes. We developed a triple staining approach, combining DNA-FISH with RNA-FISH and immunofluorescence, using peroxidase based signal amplification to accommodate each staining requirement. A major improvement is the ability to obtain, within 10 µm tissue sections, low-background signals that can be imaged at high resolution by confocal microscopy and wide-field conventional epifluorescence. Additionally, the triple staining worked with a wide range of antibodies directed against cellular and viral proteins. The complete protocol takes 2.5 days to accommodate antibody and probe penetration within the tissue.
- Published
- 2014
- Full Text
- View/download PDF
41. [The ribosome: a new player in tumorigenesis?].
- Author
-
Marcel V, Catez F, Mertani HC, and Diaz JJ
- Subjects
- Cell Transformation, Neoplastic, Humans, Neoplasms metabolism, Neoplasms pathology, Protein Biosynthesis, Carcinogenesis, Ribosomes physiology
- Published
- 2014
- Full Text
- View/download PDF
42. Ribosomes: the future of targeted therapies?
- Author
-
Marcel V, Catez F, and Diaz JJ
- Subjects
- Humans, RNA, Ribosomal genetics, RNA, Ribosomal metabolism, Antineoplastic Agents pharmacology, Ribosomes metabolism
- Published
- 2013
- Full Text
- View/download PDF
43. p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer.
- Author
-
Marcel V, Ghayad SE, Belin S, Therizols G, Morel AP, Solano-Gonzàlez E, Vendrell JA, Hacot S, Mertani HC, Albaret MA, Bourdon JC, Jordan L, Thompson A, Tafer Y, Cong R, Bouvet P, Saurin JC, Catez F, Prats AC, Puisieux A, and Diaz JJ
- Subjects
- Breast Neoplasms genetics, Breast Neoplasms metabolism, Breast Neoplasms mortality, Cell Line, Tumor, Cell Transformation, Neoplastic genetics, Chromosomal Proteins, Non-Histone metabolism, Female, Humans, Methylation, Neoplasms mortality, Peptide Chain Initiation, Translational, Prognosis, Protein Binding, Chromosomal Proteins, Non-Histone genetics, Gene Expression Regulation, Neoplastic, Neoplasms genetics, Neoplasms metabolism, Protein Biosynthesis, RNA, Ribosomal metabolism, Tumor Suppressor Protein p53 metabolism
- Abstract
Ribosomes are specialized entities that participate in regulation of gene expression through their rRNAs carrying ribozyme activity. Ribosome biogenesis is overactivated in p53-inactivated cancer cells, although involvement of p53 on ribosome quality is unknown. Here, we show that p53 represses expression of the rRNA methyl-transferase fibrillarin (FBL) by binding directly to FBL. High levels of FBL are accompanied by modifications of the rRNA methylation pattern, impairment of translational fidelity, and an increase of internal ribosome entry site (IRES)-dependent translation initiation of key cancer genes. FBL overexpression contributes to tumorigenesis and is associated with poor survival in patients with breast cancer. Thus, p53 acts as a safeguard of protein synthesis by regulating FBL and the subsequent quality and intrinsic activity of ribosomes., (Copyright © 2013 Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
44. HSV-1 genome subnuclear positioning and associations with host-cell PML-NBs and centromeres regulate LAT locus transcription during latency in neurons.
- Author
-
Catez F, Picard C, Held K, Gross S, Rousseau A, Theil D, Sawtell N, Labetoulle M, and Lomonte P
- Subjects
- Animals, Carrier Proteins genetics, Carrier Proteins metabolism, Cells, Cultured, Centromere genetics, Co-Repressor Proteins, DNA Helicases genetics, DNA Helicases metabolism, Gene Expression Regulation, Viral physiology, Herpes Simplex genetics, Humans, Intracellular Signaling Peptides and Proteins genetics, Intracellular Signaling Peptides and Proteins metabolism, Mice, Mice, Inbred BALB C, Mice, Knockout, Molecular Chaperones, Nuclear Proteins genetics, Promyelocytic Leukemia Protein, Rabbits, Transcription Factors genetics, Tumor Suppressor Proteins genetics, X-linked Nuclear Protein, Centromere metabolism, Genetic Loci physiology, Genome, Viral physiology, Herpes Simplex metabolism, Herpesvirus 1, Human physiology, Nuclear Proteins metabolism, Transcription Factors metabolism, Transcription, Genetic physiology, Tumor Suppressor Proteins metabolism, Virus Latency physiology
- Abstract
Major human pathologies are caused by nuclear replicative viruses establishing life-long latent infection in their host. During latency the genomes of these viruses are intimately interacting with the cell nucleus environment. A hallmark of herpes simplex virus type 1 (HSV-1) latency establishment is the shutdown of lytic genes expression and the concomitant induction of the latency associated (LAT) transcripts. Although the setting up and the maintenance of the latent genetic program is most likely dependent on a subtle interplay between viral and nuclear factors, this remains uninvestigated. Combining the use of in situ fluorescent-based approaches and high-resolution microscopic analysis, we show that HSV-1 genomes adopt specific nuclear patterns in sensory neurons of latently infected mice (28 days post-inoculation, d.p.i.). Latent HSV-1 genomes display two major patterns, called "Single" and "Multiple", which associate with centromeres, and with promyelocytic leukemia nuclear bodies (PML-NBs) as viral DNA-containing PML-NBs (DCP-NBs). 3D-image reconstruction of DCP-NBs shows that PML forms a shell around viral genomes and associated Daxx and ATRX, two PML partners within PML-NBs. During latency establishment (6 d.p.i.), infected mouse TGs display, at the level of the whole TG and in individual cells, a substantial increase of PML amount consistent with the interferon-mediated antiviral role of PML. "Single" and "Multiple" patterns are reminiscent of low and high-viral genome copy-containing neurons. We show that LAT expression is significantly favored within the "Multiple" pattern, which underlines a heterogeneity of LAT expression dependent on the viral genome copy number, pattern acquisition, and association with nuclear domains. Infection of PML-knockout mice demonstrates that PML/PML-NBs are involved in virus nuclear pattern acquisition, and negatively regulate the expression of the LAT. This study demonstrates that nuclear domains including PML-NBs and centromeres are functionally involved in the control of HSV-1 latency, and represent a key level of host/virus interaction.
- Published
- 2012
- Full Text
- View/download PDF
45. Centromere architecture breakdown induced by the viral E3 ubiquitin ligase ICP0 protein of herpes simplex virus type 1.
- Author
-
Gross S, Catez F, Masumoto H, and Lomonte P
- Subjects
- Aspartate Carbamoyltransferase metabolism, Autoantigens metabolism, Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing) metabolism, Centromere Protein A, Chromatin metabolism, Chromosomal Proteins, Non-Histone metabolism, Chromosomes, Artificial, Human, Dihydroorotase metabolism, HeLa Cells, Humans, Immediate-Early Proteins genetics, Multiprotein Complexes metabolism, Nucleosomes metabolism, Proteasome Endopeptidase Complex metabolism, Ubiquitin-Protein Ligases genetics, Centromere metabolism, Herpesvirus 1, Human metabolism, Immediate-Early Proteins metabolism, Ubiquitin-Protein Ligases metabolism
- Abstract
The viral E3 ubiquitin ligase ICP0 protein has the unique property to temporarily localize at interphase and mitotic centromeres early after infection of cells by the herpes simplex virus type 1 (HSV-1). As a consequence ICP0 induces the proteasomal degradation of several centromeric proteins (CENPs), namely CENP-A, the centromeric histone H3 variant, CENP-B and CENP-C. Following ICP0-induced centromere modification cells trigger a specific response to centromeres called interphase Centromere Damage Response (iCDR). The biological significance of the iCDR is unknown; so is the degree of centromere structural damage induced by ICP0. Interphase centromeres are complex structures made of proximal and distal protein layers closely associated to CENP-A-containing centromeric chromatin. Using several cell lines constitutively expressing GFP-tagged CENPs, we investigated the extent of the centromere destabilization induced by ICP0. We show that ICP0 provokes the disappearance from centromeres, and the proteasomal degradation of several CENPs from the NAC (CENP-A nucleosome associated) and CAD (CENP-A Distal) complexes. We then investigated the nucleosomal occupancy of the centromeric chromatin in ICP0-expressing cells by micrococcal nuclease (MNase) digestion analysis. ICP0 expression either following infection or in cell lines constitutively expressing ICP0 provokes significant modifications of the centromeric chromatin structure resulting in higher MNase accessibility. Finally, using human artificial chromosomes (HACs), we established that ICP0-induced iCDR could also target exogenous centromeres. These results demonstrate that, in addition to the protein complexes, ICP0 also destabilizes the centromeric chromatin resulting in the complete breakdown of the centromere architecture, which consequently induces iCDR.
- Published
- 2012
- Full Text
- View/download PDF
46. Binding and interplay of HMG proteins on chromatin: lessons from live cell imaging.
- Author
-
Catez F and Hock R
- Subjects
- Animals, Cell Survival, Humans, Protein Binding, Protein Processing, Post-Translational, Chromatin metabolism, High Mobility Group Proteins metabolism, Imaging, Three-Dimensional
- Abstract
Members of the superfamily of high mobility group (HMG) proteins are considered as architectural elements of chromatin. It is now clear that they belong to a network of dynamic chromatin proteins that constantly move around the chromatin fiber thereby dynamically modulating DNA-dependent processes. In this review we discuss how HMGs fused to fluorescent proteins and live cell imaging advanced our understanding in HMG dynamics and function. By presenting the regulation of the dynamic properties of each HMG family in comparison to one another we wish to highlight common themes among the three families, as well as stimulate new ideas from one HMG family in relation to the others and more generally in the dynamic world of chromatin., (Copyright 2009 Elsevier B.V. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
47. Activation of ATM depends on chromatin interactions occurring before induction of DNA damage.
- Author
-
Kim YC, Gerlitz G, Furusawa T, Catez F, Nussenzweig A, Oh KS, Kraemer KH, Shiloh Y, and Bustin M
- Subjects
- Acetylation radiation effects, Animals, Ataxia Telangiectasia Mutated Proteins, Cell Nucleus metabolism, Cell Nucleus radiation effects, Cells, Cultured, Enzyme Inhibitors pharmacology, Genomic Instability genetics, Histone Deacetylase Inhibitors, Histone Deacetylases metabolism, Histones genetics, Histones radiation effects, Lysine metabolism, Mice, Mice, Knockout, Phosphorylation radiation effects, Radiation, Ionizing, Cell Cycle Proteins genetics, Cell Nucleus genetics, Chromatin genetics, DNA Breaks, Double-Stranded, DNA Damage genetics, DNA-Binding Proteins genetics, HMGN1 Protein genetics, Protein Serine-Threonine Kinases genetics, Tumor Suppressor Proteins genetics
- Abstract
Efficient and correct responses to double-stranded breaks (DSB) in chromosomal DNA are crucial for maintaining genomic stability and preventing chromosomal alterations that lead to cancer. The generation of DSB is associated with structural changes in chromatin and the activation of the protein kinase ataxia-telangiectasia mutated (ATM), a key regulator of the signalling network of the cellular response to DSB. The interrelationship between DSB-induced changes in chromatin architecture and the activation of ATM is unclear. Here we show that the nucleosome-binding protein HMGN1 modulates the interaction of ATM with chromatin both before and after DSB formation, thereby optimizing its activation. Loss of HMGN1 or ablation of its ability to bind to chromatin reduces the levels of ionizing radiation (IR)-induced ATM autophosphorylation and the activation of several ATM targets. IR treatments lead to a global increase in the acetylation of Lys 14 of histone H3 (H3K14) in an HMGN1-dependent manner and treatment of cells with histone deacetylase inhibitors bypasses the HMGN1 requirement for efficient ATM activation. Thus, by regulating the levels of histone modifications, HMGN1 affects ATM activation. Our studies identify a new mediator of ATM activation and demonstrate a direct link between the steady-state intranuclear organization of ATM and the kinetics of its activation after DNA damage.
- Published
- 2009
- Full Text
- View/download PDF
48. Cell cycle-dependent binding of HMGN proteins to chromatin.
- Author
-
Cherukuri S, Hock R, Ueda T, Catez F, Rochman M, and Bustin M
- Subjects
- Animals, Cell Survival, Chromosomes, Human metabolism, Fluorescence, Genetic Complementation Test, HMGN1 Protein chemistry, HMGN2 Protein chemistry, HeLa Cells, Humans, Interphase, Mice, Mitosis, Models, Biological, Phosphorylation, Protein Binding, Protein Structure, Tertiary, Rats, Cell Cycle, Chromatin metabolism, HMGN1 Protein metabolism, HMGN2 Protein metabolism
- Abstract
Throughout the cell cycle, the histones remain associated with DNA, but the repertoire of proteins associated with the chromatin fiber continuously changes. The chromatin interaction of HMGNs, a family of nucleosome binding proteins that modulates the structure and activity of chromatin, during the cell cycle is controversial. Immunofluorescence studies demonstrated that HMGNs are not associated with chromatin, whereas live cell imaging indicated that they are present in mitotic chromosomes. To resolve this controversy, we examined the organization of wild-type and mutated HMGN1 and HMGN2 proteins in the cell nucleus by using immunofluorescence studies, live cell imaging, gel mobility shift assays, and bimolecular fluorescence complementation (BiFC). We find that during interphase, HMGNs bind specifically to nucleosomes and form homodimeric complexes that yield distinct BiFC signals. In metaphase, the nucleosomal binding domain of the protein is inactivated, and the proteins associate with chromatin with low affinity as monomers, and they do not form specific complexes. Our studies demonstrate that the mode of binding of HMGNs to chromatin is cell cycle dependent.
- Published
- 2008
- Full Text
- View/download PDF
49. Delineation of the protein module that anchors HMGN proteins to nucleosomes in the chromatin of living cells.
- Author
-
Ueda T, Catez F, Gerlitz G, and Bustin M
- Subjects
- Amino Acid Motifs, Amino Acid Sequence, Animals, Cells, Cultured, HMGN1 Protein genetics, HMGN2 Protein genetics, Mice, Mice, Knockout, Molecular Sequence Data, Mutation, Protein Binding, Chromatin metabolism, HMGN1 Protein metabolism, HMGN2 Protein metabolism, Nucleosomes metabolism
- Abstract
Numerous nuclear proteins bind to chromatin by targeting unique DNA sequences or specific histone modifications. In contrast, HMGN proteins recognize the generic structure of the 147-bp nucleosome core particle. HMGNs alter the structure and activity of chromatin by binding to nucleosomes; however, the determinants of the specific interaction of HMGNs with chromatin are not known. Here we use systematic mutagenesis, quantitative fluorescence recovery after photobleaching, fluorescence imaging, and mobility shift assays to identify the determinants important for the specific binding of these proteins to both the chromatin of living cells and to purified nucleosomes. We find that several regions of the protein affect the affinity of HMGNs to chromatin; however, the conserved sequence RRSARLSA, is the sole determinant of the specific interaction of HMGNs with nucleosomes. Within this sequence, each of the 4 amino acids in the R-S-RL motif are the only residues absolutely essential for anchoring HMGN protein to nucleosomes, both in vivo and in vitro. Our studies identify a new chromatin-binding module that specifically recognizes nucleosome cores independently of DNA sequence or histone tail modifications.
- Published
- 2008
- Full Text
- View/download PDF
50. A novel cell response triggered by interphase centromere structural instability.
- Author
-
Morency E, Sabra M, Catez F, Texier P, and Lomonte P
- Subjects
- Animals, Cells, Cultured, Centromere metabolism, Centromere ultrastructure, Centromere Protein B antagonists & inhibitors, Chromosomal Proteins, Non-Histone metabolism, Cyclic AMP Response Element-Binding Protein metabolism, DNA Breaks, DNA, Satellite metabolism, Herpesvirus 1, Human metabolism, Humans, Immediate-Early Proteins physiology, Kinetochores metabolism, Kinetochores ultrastructure, Mice, Nerve Tissue Proteins metabolism, Nuclear Proteins metabolism, RNA Interference, RNA-Binding Proteins metabolism, SMN Complex Proteins, Ubiquitin-Protein Ligases physiology, Centromere chemistry, Interphase physiology
- Abstract
Interphase centromeres are crucial domains for the proper assembly of kinetochores at the onset of mitosis. However, it is not known whether the centromere structure is under tight control during interphase. This study uses the peculiar property of the infected cell protein 0 of herpes simplex virus type 1 to induce centromeric structural damage, revealing a novel cell response triggered by centromere destabilization. It involves centromeric accumulation of the Cajal body-associated coilin and fibrillarin as well as the survival motor neuron proteins. The response, which we have termed interphase centromere damage response (iCDR), was observed in all tested human and mouse cells, indicative of a conserved mechanism. Knockdown cells for several constitutive centromere proteins have shown that the loss of centromeric protein B provokes the centromeric accumulation of coilin. We propose that the iCDR is part of a novel safeguard mechanism that is dedicated to maintaining interphase centromeres compatible with the correct assembly of kinetochores, microtubule binding, and completion of mitosis.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.